Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Corium International Inc patents


Recent patent applications related to Corium International Inc. Corium International Inc is listed as an Agent/Assignee. Note: Corium International Inc may have other listings under different names/spellings. We're not affiliated with Corium International Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Corium International Inc-related inventors


Transdermal adhesive composition comprising a poorly soluble therapeutic agent

Methods, compositions, and devices for transdermally administering an active agent such as donepezil are provided.. . ... Corium International Inc

Sodium bicarbonate in situ conversion driven transdermal delivery of amine drug

Compositions, devices, and methods for transdermal administration of active agents provided in their salt form instead of neutral form are provided.. . ... Corium International Inc

Donepezil transdermal delivery system

A transdermal delivery system for systemic delivery of donepezil is described, where the system comprises an adhesive matrix drug reservoir layer comprised of a copolymer of acrylic acid/vinyl acetate, triethyl citrate, and donepezil base generated in situ by reaction of donepezil hcl and an alkaline salt. The system is provided for treatment of alzheimer's disease, and achieves transdermal delivery of the therapeutic agent at steady state that is bioequivalent to administration of the therapeutic agent orally.. ... Corium International Inc

Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery

A method for delivering a therapeutic agent to a subject from a transdermal delivery system is described, where the therapeutic agent (i) has a half-life in the blood when delivered orally of greater than about 48 hours and (ii) is for the treatment of a chronic condition. The transdermal delivery system achieves transdermal delivery of the therapeutic agent at steady state that is bioequivalent to administration of the therapeutic agent orally, wherein bioequivalency is established by (a) a 90% confidence interval of the relative mean cmax and auc of the therapeutic agent administered from the transdermal delivery system and via oral delivery between 0.70 and 1.43 or between 0.80 and 1.25, or (b) a 90% confidence interval of the ratios for auc and cmax of the therapeutic agent administered from the transdermal delivery system and via oral delivery between 0.70 and 1.43 or between 0.80 and 1.25.. ... Corium International Inc

Memantine transdermal delivery systems

Transdermal delivery systems for the systemic delivery of memantine are described, wherein the system comprises a drug reservoir layer and an adhesive layer, optionally together with one or more intermediate and/or supporting layers, wherein the drug reservoir layer comprises an acrylate polymer or copolymer, a permeation enhancer, a carrier, and memantine base generated in situ by reaction of a memantine salt and an alkaline salt. Compositions and kits comprising the various components, e.g., drug reservoir and/or adhesive compositions are described. ... Corium International Inc

Transdermal formulation and delivery method of low solubility or unstable unionized neutral drugs by in situ salt-to-neutral drug conversion of salt drug

Compositions, devices, and methods for transdermal administration of active agents provided in their salt form instead of neutral form are provided.. . ... Corium International Inc

Donepezil transdermal delivery system

A transdermal delivery system for systemic delivery of donepezil is described, where the system comprises an adhesive matrix drug reservoir layer comprised of a copolymer of acrylic acid/vinyl acetate, triethyl citrate, and donepezil base generated in situ by reaction of donepezil hcl and an alkaline salt. The system is provided for treatment of alzheimer's disease, and achieves transdermal delivery of the therapeutic agent at steady state that is bioequivalent to administration of the therapeutic agent orally.. ... Corium International Inc

Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery

A method for delivering a therapeutic agent to a subject from a transdermal delivery system is described, where the therapeutic agent (i) has a half-life in the blood when delivered orally of greater than about 48 hours and (ii) is for the treatment of a chronic condition. The transdermal delivery system achieves transdermal delivery of the therapeutic agent at steady state that is bioequivalent to administration of the therapeutic agent orally, wherein bioequivalency is established by (a) a 90% confidence interval of the relative mean cmax and auc of the therapeutic agent administered from the transdermal delivery system and via oral delivery between 0.70 and 1.43 or between 0.80 and 1.25, or (b) a 90% confidence interval of the ratios for auc and cmax of the therapeutic agent administered from the transdermal delivery system and via oral delivery between 0.70 and 1.43 or between 0.80 and 1.25.. ... Corium International Inc

Applicators for microneedles

An applicator for a microprojection array is described. In one embodiment, the applicator comprises an energy-storing element. ... Corium International Inc

Method and device for transdermal delivery of parathyroid hormone using a microprojection array

A method and a drug delivery system for transdermally administering parathyroid hormone (pth) in a pulsatile fashion are provided, where the drug delivery system comprises an array of microprojections each comprising pth.. . ... Corium International Inc

Hydrogel compositions for tooth whitening

A composition is provided, wherein the composition comprises a water-swellable, waterinsoluble polymer, a blend of a hydrophilic polymer and a complementary oligomer capable of hydrogen bonding to the hydrophilic polymer, and a whitening agent, preferably a peroxide. The composition finds utility as a tooth whitening composition and is applied to the teeth in need of whitening, and then removed when the degree of whitening has been achieved. ... Corium International Inc

Systems comprising a composite backing and methods for long term transdermal administration

Devices, systems, compositions and methods for long term or prolonged transdermal administration of an active agent are provided.. . ... Corium International Inc

Systems and methods for long term transdermal administration

Devices, systems, compositions and methods for long term or prolonged transdermal administration of an active agent are provided.. . ... Corium International Inc

Transdermal administration of tamsulosin

In an aspect of the invention, a composition for making a patch for the transdermal delivery of tamsulosin is provided. The composition comprises (a) at least about 1 wt % tamsulosin or a pharmaceutically acceptable salt of tamsulosin, (b) at least about 40 wt % polyisobutylene adhesive or hydrophobic synthetic rubber adhesive, (c) about 1-20 wt % of an aprotic solvent in which tamsulosin dissolves readily, (d) about 1-20 wt % of an unsaturated fatty acid or an alpha-hydroxy acid or a mixture of unsaturated fatty acids or alpha-hydroxy acids or of both unsaturated fatty acids and alpha-hydroxy acids, (e) a lipophilic permeation enhancer, and (f) a matrix modifier.. ... Corium International Inc

03/16/17 / #20170071833

Hydrogel compositions for tooth whitening

A composition is provided, wherein the composition comprises a water-swellable, water insoluble polymer, a blend of a hydrophilic polymer and a complementary oligomer capable of hydrogen bonding to the hydrophilic polymer, and a whitening agent, preferably a peroxide. The composition finds utility as a tooth whitening composition and is applied to the teeth in need of whitening, and then removed when the degree of whitening has been achieved. ... Corium International Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Corium International Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Corium International Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###